The Chinese city of Shanghai started administering an inhalable version of the CanSino COVID-19 vaccine called Convidecia Air on Wednesday, Oct. 26, 2022, in what appears to be a world first.

Combined regimen of inhalable STING agonist plus chemoimmunotherapy in platinum-resistant or platinum-refratory ovarian cancer: A randomized, open-label, phase II trial. Authors: Yan Zhang, Qian Mei, ...

A logo of China's vaccine specialist CanSino Biologics Inc is pictured on the company's branch office building in Shanghai, China, Feb 25, 2022. [Photo/IC] An inhaled COVID-19 vaccine developed by ...

No severe adverse events were reported. As for immunogenicity, participants who received the inhalable vaccine as a booster had generated an 18.4 to 26.4 times higher level of neutralizing antibodies.

The world's first aerosolized inhalable adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) is progressing well toward obtaining emergency-use approval, and it is expected to be in wide use ...

Lung cancer screening dramatically increases long-term survival The team also examined the safety profile of the inhalable ABNs, and saw no general toxicity or clogging of vasculature in mice seven ...

A new powdered, inhalable vaccine could provide better protection against respiratory viral infections than traditional injectable vaccines, according to the Chinese researchers who developed it ...

They tested its response against “co-circulating strains and transmission of the Omicron variant.” As a result, the inhalable vaccine could fight against COVID-19 and other respiratory diseases.

Developing inhalable vaccines is challenging for a number of reasons. For example, the vaccine must be able to slip through physiological barriers like the respiratory mucosal layer, and there has ...

Exubera, the inhalable insulin finally approved in both the US and Europe in late January, has been touted by many industry analysts as a drug with a $2–3 billion sales potential. The product's ...

Inhalable Biologics Market Inhalable Biologics Market Dublin, March 18, 2025 (GLOBE NEWSWIRE) -- The "Inhalable Biologics Market Size, Share & Trends Analysis Report by Biologics (Peptides ...